Optical detection of malignancy during percutaneous interventions.
- Conditions
- Pulmonary Coin LesionColon Cancer Liver Metastasis
- Registration Number
- NL-OMON21152
- Lead Sponsor
- Philips Healthcare
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 70
Inclusion Criteria
1. Patients with a suspicious lesion in lung or liver who are scheduled for a standard core biopsy procedure;
2. Patient planned for percutaneous RFA of colorectal liver metastasis;
Exclusion Criteria
1. Patients who have higher risk of bleeding;
2. Patients with suspected sensitivity to light; e.g. patients who have had photodynamic therapy.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Differentiation between normal and malignant tissue. Statistical analysis of the difference between diffuse reflectance spectra obtained at normal and malignant measurement locations.
- Secondary Outcome Measures
Name Time Method